Form 8-K INSMED Inc For: May 09

Go back to Form 8-K INSMED Inc For: May 09

Insmed (INSM) PT Raised to $43 at Morgan Stanley

May 9, 2024 12:11 PM EDT

Morgan Stanley analyst Jeffrey Hung raised the price target on Insmed (NASDAQ: INSM) to $43.00 (from $40.00) while maintaining a Overweight rating.

The analyst comments "Insmed reported 1Q Arikayce sales of $75.5M (consensus: $78M) and reiterated guidance 2024 Arikayce revenue guidance of $340M-360M. The company... More